Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

Certara2025 年 11 月 5 日

On-Demand Webinar

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

Certara2025 年 11 月 3 日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025 年 10 月 31 日

Blog

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

Certara2025 年 10 月 24 日

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

Certara2025 年 10 月 21 日

Blog

关于 SDTM 您需要了解的一切

Find out all you need to know about CDISC SDTM, from the SDTM implementation guide…

Certara2025 年 10 月 16 日

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

Certara2025 年 10 月 15 日

On-Demand Webinar

RAPS 赞助的网络研讨会：Planning and Preparing Regulatory Submissions Using Top-down Messaging

Access our on-demand webinar and explore proven strategies to develop consistent, high-impact regulatory submission messages.

Certara2025 年 10 月 9 日

Conference

ICAComP 2025

Certara2025 年 10 月 8 日

Conference

Dutch Medicines Days

Certara2025 年 10 月 7 日

药物开发

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

关于 SDTM 您需要了解的一切

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

RAPS 赞助的网络研讨会：Planning and Preparing Regulatory Submissions Using Top-down Messaging

ICAComP 2025

Dutch Medicines Days

订阅时事通讯

快捷链接

解决方案

联系我们